nodes	percent_of_prediction	percent_of_DWPC	metapath
Erythromycin—SLC22A7—Fluorouracil—head and neck cancer	0.186	0.216	CbGbCtD
Erythromycin—SLC22A7—Docetaxel—head and neck cancer	0.142	0.165	CbGbCtD
Erythromycin—ABCC1—Vinblastine—head and neck cancer	0.135	0.157	CbGbCtD
Erythromycin—ABCC1—Docetaxel—head and neck cancer	0.112	0.129	CbGbCtD
Erythromycin—CYP3A7-CYP3A51P—Docetaxel—head and neck cancer	0.0551	0.0639	CbGbCtD
Erythromycin—CYP3A7—Docetaxel—head and neck cancer	0.0551	0.0639	CbGbCtD
Erythromycin—CYP3A5—Docetaxel—head and neck cancer	0.0414	0.048	CbGbCtD
Erythromycin—CYP1A2—Fluorouracil—head and neck cancer	0.0403	0.0468	CbGbCtD
Erythromycin—ABCB1—Vinblastine—head and neck cancer	0.0327	0.0379	CbGbCtD
Erythromycin—ABCB1—Docetaxel—head and neck cancer	0.0269	0.0312	CbGbCtD
Erythromycin—CYP3A4—Vinblastine—head and neck cancer	0.0196	0.0227	CbGbCtD
Erythromycin—CYP3A4—Docetaxel—head and neck cancer	0.0161	0.0187	CbGbCtD
Erythromycin—Superinfection—Fluorouracil—head and neck cancer	0.00652	0.0857	CcSEcCtD
Erythromycin—Skin irritation—Fluorouracil—head and neck cancer	0.00342	0.045	CcSEcCtD
Erythromycin—Eruption—Hydroxyurea—head and neck cancer	0.00334	0.0439	CcSEcCtD
Erythromycin—Hepatotoxicity—Hydroxyurea—head and neck cancer	0.00266	0.035	CcSEcCtD
Erythromycin—Tenderness—Hydroxyurea—head and neck cancer	0.00236	0.031	CcSEcCtD
Erythromycin—Skin exfoliation—Hydroxyurea—head and neck cancer	0.00196	0.0258	CcSEcCtD
Erythromycin—Deafness—Vinblastine—head and neck cancer	0.00183	0.0241	CcSEcCtD
Erythromycin—Eruption—Docetaxel—head and neck cancer	0.00174	0.0228	CcSEcCtD
Erythromycin—Eye irritation—Fluorouracil—head and neck cancer	0.00173	0.0228	CcSEcCtD
Erythromycin—Tenderness—Fluorouracil—head and neck cancer	0.0017	0.0223	CcSEcCtD
Erythromycin—Redness—Docetaxel—head and neck cancer	0.00158	0.0208	CcSEcCtD
Erythromycin—Burning sensation—Docetaxel—head and neck cancer	0.00154	0.0202	CcSEcCtD
Erythromycin—Hepatotoxicity—Docetaxel—head and neck cancer	0.00138	0.0182	CcSEcCtD
Erythromycin—Pancreatitis—Hydroxyurea—head and neck cancer	0.00126	0.0166	CcSEcCtD
Erythromycin—Eye irritation—Docetaxel—head and neck cancer	0.00125	0.0164	CcSEcCtD
Erythromycin—Hearing impaired—Docetaxel—head and neck cancer	0.00112	0.0148	CcSEcCtD
Erythromycin—Hallucination—Hydroxyurea—head and neck cancer	0.00103	0.0135	CcSEcCtD
Erythromycin—Irritability—Fluorouracil—head and neck cancer	0.00103	0.0135	CcSEcCtD
Erythromycin—Skin exfoliation—Docetaxel—head and neck cancer	0.00102	0.0134	CcSEcCtD
Erythromycin—Erythema—Hydroxyurea—head and neck cancer	0.000899	0.0118	CcSEcCtD
Erythromycin—Vertigo—Vinblastine—head and neck cancer	0.000886	0.0116	CcSEcCtD
Erythromycin—Deafness—Docetaxel—head and neck cancer	0.000867	0.0114	CcSEcCtD
Erythromycin—Convulsion—Vinblastine—head and neck cancer	0.000854	0.0112	CcSEcCtD
Erythromycin—Discomfort—Vinblastine—head and neck cancer	0.000829	0.0109	CcSEcCtD
Erythromycin—Convulsion—Hydroxyurea—head and neck cancer	0.000779	0.0102	CcSEcCtD
Erythromycin—Anorexia—Vinblastine—head and neck cancer	0.000767	0.0101	CcSEcCtD
Erythromycin—Discomfort—Hydroxyurea—head and neck cancer	0.000756	0.00994	CcSEcCtD
Erythromycin—Liver function test abnormal—Docetaxel—head and neck cancer	0.000716	0.00941	CcSEcCtD
Erythromycin—Anorexia—Hydroxyurea—head and neck cancer	0.000699	0.00919	CcSEcCtD
Erythromycin—Decreased appetite—Vinblastine—head and neck cancer	0.000699	0.00919	CcSEcCtD
Erythromycin—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.000698	0.00918	CcSEcCtD
Erythromycin—Pain—Vinblastine—head and neck cancer	0.000688	0.00904	CcSEcCtD
Erythromycin—Arrhythmia—Fluorouracil—head and neck cancer	0.000664	0.00873	CcSEcCtD
Erythromycin—Feeling abnormal—Vinblastine—head and neck cancer	0.000663	0.00871	CcSEcCtD
Erythromycin—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000658	0.00865	CcSEcCtD
Erythromycin—Erythema—Fluorouracil—head and neck cancer	0.000647	0.00851	CcSEcCtD
Erythromycin—Decreased appetite—Hydroxyurea—head and neck cancer	0.000638	0.00838	CcSEcCtD
Erythromycin—Abdominal pain—Vinblastine—head and neck cancer	0.000636	0.00836	CcSEcCtD
Erythromycin—Pain—Hydroxyurea—head and neck cancer	0.000627	0.00825	CcSEcCtD
Erythromycin—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000605	0.00795	CcSEcCtD
Erythromycin—Hypersensitivity—Vinblastine—head and neck cancer	0.000593	0.00779	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000592	0.00779	CcSEcCtD
Erythromycin—Jaundice—Docetaxel—head and neck cancer	0.000582	0.00766	CcSEcCtD
Erythromycin—Convulsion—Fluorouracil—head and neck cancer	0.000561	0.00737	CcSEcCtD
Erythromycin—Chest pain—Fluorouracil—head and neck cancer	0.000551	0.00724	CcSEcCtD
Erythromycin—Diarrhoea—Vinblastine—head and neck cancer	0.00055	0.00724	CcSEcCtD
Erythromycin—Discomfort—Fluorouracil—head and neck cancer	0.000544	0.00715	CcSEcCtD
Erythromycin—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00054	0.00711	CcSEcCtD
Erythromycin—Hepatitis—Docetaxel—head and neck cancer	0.000536	0.00705	CcSEcCtD
Erythromycin—Confusional state—Fluorouracil—head and neck cancer	0.000532	0.007	CcSEcCtD
Erythromycin—Dizziness—Vinblastine—head and neck cancer	0.000532	0.00699	CcSEcCtD
Erythromycin—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000528	0.00694	CcSEcCtD
Erythromycin—Vomiting—Vinblastine—head and neck cancer	0.000511	0.00672	CcSEcCtD
Erythromycin—Erythema multiforme—Docetaxel—head and neck cancer	0.000507	0.00667	CcSEcCtD
Erythromycin—Anorexia—Fluorouracil—head and neck cancer	0.000503	0.00662	CcSEcCtD
Erythromycin—Diarrhoea—Hydroxyurea—head and neck cancer	0.000502	0.0066	CcSEcCtD
Erythromycin—Dizziness—Hydroxyurea—head and neck cancer	0.000485	0.00638	CcSEcCtD
Erythromycin—Arrhythmia—Docetaxel—head and neck cancer	0.000479	0.0063	CcSEcCtD
Erythromycin—Nausea—Vinblastine—head and neck cancer	0.000478	0.00628	CcSEcCtD
Erythromycin—Erythema—Docetaxel—head and neck cancer	0.000467	0.00614	CcSEcCtD
Erythromycin—Vomiting—Hydroxyurea—head and neck cancer	0.000466	0.00613	CcSEcCtD
Erythromycin—Rash—Hydroxyurea—head and neck cancer	0.000463	0.00608	CcSEcCtD
Erythromycin—Decreased appetite—Fluorouracil—head and neck cancer	0.000459	0.00603	CcSEcCtD
Erythromycin—Dysgeusia—Docetaxel—head and neck cancer	0.000457	0.00601	CcSEcCtD
Erythromycin—Pain—Fluorouracil—head and neck cancer	0.000452	0.00594	CcSEcCtD
Erythromycin—Nausea—Hydroxyurea—head and neck cancer	0.000436	0.00573	CcSEcCtD
Erythromycin—Feeling abnormal—Fluorouracil—head and neck cancer	0.000435	0.00572	CcSEcCtD
Erythromycin—Urticaria—Fluorouracil—head and neck cancer	0.000419	0.00551	CcSEcCtD
Erythromycin—Palpitations—Docetaxel—head and neck cancer	0.000413	0.00543	CcSEcCtD
Erythromycin—Convulsion—Docetaxel—head and neck cancer	0.000405	0.00532	CcSEcCtD
Erythromycin—Chest pain—Docetaxel—head and neck cancer	0.000398	0.00523	CcSEcCtD
Erythromycin—Hypersensitivity—Fluorouracil—head and neck cancer	0.000389	0.00511	CcSEcCtD
Erythromycin—Confusional state—Docetaxel—head and neck cancer	0.000384	0.00505	CcSEcCtD
Erythromycin—Anaphylactic shock—Docetaxel—head and neck cancer	0.000381	0.00501	CcSEcCtD
Erythromycin—Pruritus—Fluorouracil—head and neck cancer	0.000374	0.00491	CcSEcCtD
Erythromycin—Anorexia—Docetaxel—head and neck cancer	0.000363	0.00478	CcSEcCtD
Erythromycin—Diarrhoea—Fluorouracil—head and neck cancer	0.000361	0.00475	CcSEcCtD
Erythromycin—Dizziness—Fluorouracil—head and neck cancer	0.000349	0.00459	CcSEcCtD
Erythromycin—Vomiting—Fluorouracil—head and neck cancer	0.000336	0.00441	CcSEcCtD
Erythromycin—SLC22A7—Fluoropyrimidine Activity—TP53—head and neck cancer	0.000336	0.00544	CbGpPWpGaD
Erythromycin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000333	0.0054	CbGpPWpGaD
Erythromycin—Rash—Fluorouracil—head and neck cancer	0.000333	0.00438	CcSEcCtD
Erythromycin—Decreased appetite—Docetaxel—head and neck cancer	0.000331	0.00436	CcSEcCtD
Erythromycin—MLNR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—head and neck cancer	0.000327	0.0053	CbGpPWpGaD
Erythromycin—Pain—Docetaxel—head and neck cancer	0.000326	0.00428	CcSEcCtD
Erythromycin—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.00032	0.00518	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—KISS1—head and neck cancer	0.000317	0.00513	CbGpPWpGaD
Erythromycin—CYP3A7—Biological oxidations—NAT2—head and neck cancer	0.000317	0.00513	CbGpPWpGaD
Erythromycin—Feeling abnormal—Docetaxel—head and neck cancer	0.000314	0.00413	CcSEcCtD
Erythromycin—Nausea—Fluorouracil—head and neck cancer	0.000314	0.00412	CcSEcCtD
Erythromycin—CYP3A7—Metapathway biotransformation—NAT2—head and neck cancer	0.000312	0.00506	CbGpPWpGaD
Erythromycin—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000312	0.0041	CcSEcCtD
Erythromycin—MLNR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—head and neck cancer	0.000311	0.00504	CbGpPWpGaD
Erythromycin—MLNR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—head and neck cancer	0.000311	0.00504	CbGpPWpGaD
Erythromycin—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000303	0.00491	CbGpPWpGaD
Erythromycin—MLNR—G alpha (q) signalling events—PIK3CA—head and neck cancer	0.000302	0.00489	CbGpPWpGaD
Erythromycin—Abdominal pain—Docetaxel—head and neck cancer	0.000301	0.00396	CcSEcCtD
Erythromycin—Hypersensitivity—Docetaxel—head and neck cancer	0.000281	0.00369	CcSEcCtD
Erythromycin—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000279	0.00452	CbGpPWpGaD
Erythromycin—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000279	0.00452	CbGpPWpGaD
Erythromycin—ABCC1—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000272	0.0044	CbGpPWpGaD
Erythromycin—MLNR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	0.00027	0.00438	CbGpPWpGaD
Erythromycin—Pruritus—Docetaxel—head and neck cancer	0.00027	0.00354	CcSEcCtD
Erythromycin—CYP1A2—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000268	0.00435	CbGpPWpGaD
Erythromycin—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000268	0.00434	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—GRP—head and neck cancer	0.000261	0.00423	CbGpPWpGaD
Erythromycin—Diarrhoea—Docetaxel—head and neck cancer	0.000261	0.00343	CcSEcCtD
Erythromycin—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000255	0.00413	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—STAT6—head and neck cancer	0.000253	0.0041	CbGpPWpGaD
Erythromycin—Dizziness—Docetaxel—head and neck cancer	0.000252	0.00331	CcSEcCtD
Erythromycin—CYP2B6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000251	0.00407	CbGpPWpGaD
Erythromycin—MLNR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	0.00025	0.00405	CbGpPWpGaD
Erythromycin—SLC22A7—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.00025	0.00405	CbGpPWpGaD
Erythromycin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000249	0.00403	CbGpPWpGaD
Erythromycin—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000246	0.00398	CbGpPWpGaD
Erythromycin—Vomiting—Docetaxel—head and neck cancer	0.000242	0.00319	CcSEcCtD
Erythromycin—Rash—Docetaxel—head and neck cancer	0.00024	0.00316	CcSEcCtD
Erythromycin—CYP1A2—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.000236	0.00383	CbGpPWpGaD
Erythromycin—CYP1A2—Phase II conjugation—NAT2—head and neck cancer	0.000236	0.00382	CbGpPWpGaD
Erythromycin—CYP2B6—Biological oxidations—NAT2—head and neck cancer	0.000234	0.0038	CbGpPWpGaD
Erythromycin—CYP2B6—Metapathway biotransformation—NAT2—head and neck cancer	0.000231	0.00374	CbGpPWpGaD
Erythromycin—CYP3A5—Biological oxidations—NAT2—head and neck cancer	0.000229	0.00371	CbGpPWpGaD
Erythromycin—Nausea—Docetaxel—head and neck cancer	0.000226	0.00298	CcSEcCtD
Erythromycin—CYP3A5—Metapathway biotransformation—NAT2—head and neck cancer	0.000226	0.00366	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—YAP1—head and neck cancer	0.000224	0.00363	CbGpPWpGaD
Erythromycin—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000206	0.00335	CbGpPWpGaD
Erythromycin—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000202	0.00327	CbGpPWpGaD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000186	0.00302	CbGpPWpGaD
Erythromycin—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000185	0.00301	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.000185	0.00301	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.000185	0.00301	CbGpPWpGaD
Erythromycin—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000175	0.00284	CbGpPWpGaD
Erythromycin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—head and neck cancer	0.000174	0.00283	CbGpPWpGaD
Erythromycin—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000173	0.00281	CbGpPWpGaD
Erythromycin—ABCC1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000168	0.00272	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—UROD—head and neck cancer	0.000166	0.00269	CbGpPWpGaD
Erythromycin—CYP3A7—Biological oxidations—GSTM1—head and neck cancer	0.000156	0.00253	CbGpPWpGaD
Erythromycin—CYP3A7—Metapathway biotransformation—GSTM1—head and neck cancer	0.000154	0.0025	CbGpPWpGaD
Erythromycin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00015	0.00243	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—UROD—head and neck cancer	0.000149	0.00242	CbGpPWpGaD
Erythromycin—CYP3A7—Biological oxidations—CYP1A1—head and neck cancer	0.000148	0.0024	CbGpPWpGaD
Erythromycin—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000148	0.0024	CbGpPWpGaD
Erythromycin—CYP3A7—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000146	0.00237	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000145	0.00235	CbGpPWpGaD
Erythromycin—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000143	0.00232	CbGpPWpGaD
Erythromycin—CYP1A2—Biological oxidations—NAT2—head and neck cancer	0.000138	0.00223	CbGpPWpGaD
Erythromycin—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	0.000136	0.0022	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000132	0.00214	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—UROD—head and neck cancer	0.00013	0.00211	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—IL2—head and neck cancer	0.00013	0.0021	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000129	0.00209	CbGpPWpGaD
Erythromycin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000121	0.00197	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—IL2—head and neck cancer	0.000118	0.00191	CbGpPWpGaD
Erythromycin—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	0.000116	0.00189	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000116	0.00188	CbGpPWpGaD
Erythromycin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000116	0.00188	CbGpPWpGaD
Erythromycin—CYP2B6—Biological oxidations—GSTM1—head and neck cancer	0.000116	0.00187	CbGpPWpGaD
Erythromycin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000114	0.00185	CbGpPWpGaD
Erythromycin—CYP2B6—Metapathway biotransformation—GSTM1—head and neck cancer	0.000114	0.00185	CbGpPWpGaD
Erythromycin—CYP3A5—Biological oxidations—GSTM1—head and neck cancer	0.000113	0.00183	CbGpPWpGaD
Erythromycin—CYP3A5—Metapathway biotransformation—GSTM1—head and neck cancer	0.000111	0.00181	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.00011	0.00179	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—CASP8—head and neck cancer	0.00011	0.00178	CbGpPWpGaD
Erythromycin—CYP2B6—Biological oxidations—CYP1A1—head and neck cancer	0.00011	0.00178	CbGpPWpGaD
Erythromycin—CYP2B6—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000108	0.00175	CbGpPWpGaD
Erythromycin—CYP3A5—Biological oxidations—CYP1A1—head and neck cancer	0.000107	0.00174	CbGpPWpGaD
Erythromycin—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000106	0.00172	CbGpPWpGaD
Erythromycin—CYP3A5—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000106	0.00171	CbGpPWpGaD
Erythromycin—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000105	0.0017	CbGpPWpGaD
Erythromycin—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000103	0.00167	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.000102	0.00166	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—NOTCH1—head and neck cancer	0.000101	0.00164	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—UROD—head and neck cancer	9.64e-05	0.00156	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—MAPK3—head and neck cancer	9.46e-05	0.00153	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—UROD—head and neck cancer	9.42e-05	0.00153	CbGpPWpGaD
Erythromycin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	9.38e-05	0.00152	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—MAPK1—head and neck cancer	9e-05	0.00146	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—EGFR—head and neck cancer	9e-05	0.00146	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	8.68e-05	0.00141	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—PIK3CA—head and neck cancer	8.6e-05	0.00139	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—IL2—head and neck cancer	8.3e-05	0.00135	CbGpPWpGaD
Erythromycin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	8.15e-05	0.00132	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	7.98e-05	0.00129	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	7.93e-05	0.00129	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	7.82e-05	0.00127	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	7.81e-05	0.00127	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	7.81e-05	0.00127	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—PIK3CA—head and neck cancer	7.81e-05	0.00127	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	7.33e-05	0.00119	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	7.25e-05	0.00118	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—HRAS—head and neck cancer	7.23e-05	0.00117	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—UROD—head and neck cancer	7.11e-05	0.00115	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	7.06e-05	0.00114	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—AKT1—head and neck cancer	7.03e-05	0.00114	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—IL2—head and neck cancer	6.95e-05	0.00113	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—NAT2—head and neck cancer	6.9e-05	0.00112	CbGpPWpGaD
Erythromycin—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	6.81e-05	0.0011	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CCND1—head and neck cancer	6.78e-05	0.0011	CbGpPWpGaD
Erythromycin—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	6.71e-05	0.00109	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	6.59e-05	0.00107	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—PTEN—head and neck cancer	6.54e-05	0.00106	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	6.53e-05	0.00106	CbGpPWpGaD
Erythromycin—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	6.45e-05	0.00105	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—AKT1—head and neck cancer	6.38e-05	0.00103	CbGpPWpGaD
Erythromycin—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	6.37e-05	0.00103	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	6.27e-05	0.00102	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—NAT2—head and neck cancer	6.21e-05	0.00101	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—DPYD—head and neck cancer	6.05e-05	0.000981	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—VEGFA—head and neck cancer	5.91e-05	0.000958	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—STAT3—head and neck cancer	5.85e-05	0.000948	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—YAP1—head and neck cancer	5.74e-05	0.00093	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—UROD—head and neck cancer	5.68e-05	0.00092	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—MAPK3—head and neck cancer	5.59e-05	0.000906	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—DPYD—head and neck cancer	5.44e-05	0.000882	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	5.42e-05	0.000879	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—NAT2—head and neck cancer	5.41e-05	0.000878	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—MAPK1—head and neck cancer	5.32e-05	0.000862	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—EGFR—head and neck cancer	5.32e-05	0.000862	CbGpPWpGaD
Erythromycin—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	5.25e-05	0.000852	CbGpPWpGaD
Erythromycin—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	5.2e-05	0.000843	CbGpPWpGaD
Erythromycin—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	5.18e-05	0.00084	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—YAP1—head and neck cancer	5.16e-05	0.000837	CbGpPWpGaD
Erythromycin—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	4.98e-05	0.000807	CbGpPWpGaD
Erythromycin—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	4.91e-05	0.000796	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—DPYD—head and neck cancer	4.75e-05	0.00077	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	4.65e-05	0.000754	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—PIK3CA—head and neck cancer	4.61e-05	0.000748	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—YAP1—head and neck cancer	4.5e-05	0.00073	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—TP53—head and neck cancer	4.46e-05	0.000724	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	4.42e-05	0.000717	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	4.4e-05	0.000714	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—UROD—head and neck cancer	4.38e-05	0.00071	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	4.31e-05	0.000699	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—HRAS—head and neck cancer	4.27e-05	0.000692	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—NAT2—head and neck cancer	4e-05	0.000649	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	3.99e-05	0.000648	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—NAT2—head and neck cancer	3.91e-05	0.000634	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.88e-05	0.000629	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	3.86e-05	0.000625	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—AKT1—head and neck cancer	3.77e-05	0.000611	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.76e-05	0.00061	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—DPYD—head and neck cancer	3.51e-05	0.000569	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	3.48e-05	0.000565	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—TYMS—head and neck cancer	3.45e-05	0.000559	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—DPYD—head and neck cancer	3.43e-05	0.000556	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—GSTM1—head and neck cancer	3.41e-05	0.000552	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.38e-05	0.000549	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—YAP1—head and neck cancer	3.33e-05	0.00054	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	3.29e-05	0.000534	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—GPX1—head and neck cancer	3.26e-05	0.000529	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—YAP1—head and neck cancer	3.26e-05	0.000528	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—CYP1A1—head and neck cancer	3.23e-05	0.000524	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	3.13e-05	0.000508	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	3.13e-05	0.000508	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—TYMS—head and neck cancer	3.1e-05	0.000503	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—GSTM1—head and neck cancer	3.07e-05	0.000497	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—NAT2—head and neck cancer	2.95e-05	0.000479	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—GPX1—head and neck cancer	2.94e-05	0.000476	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—CYP1A1—head and neck cancer	2.91e-05	0.000471	CbGpPWpGaD
Erythromycin—ABCC1—Disease—NOTCH1—head and neck cancer	2.78e-05	0.000451	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	2.72e-05	0.000441	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—TYMS—head and neck cancer	2.7e-05	0.000439	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—GSTM1—head and neck cancer	2.67e-05	0.000433	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.65e-05	0.00043	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	2.63e-05	0.000427	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—DPYD—head and neck cancer	2.59e-05	0.00042	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—GPX1—head and neck cancer	2.56e-05	0.000415	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—CYP1A1—head and neck cancer	2.53e-05	0.000411	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.5e-05	0.000406	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.48e-05	0.000402	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—YAP1—head and neck cancer	2.46e-05	0.000398	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.39e-05	0.000387	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—NAT2—head and neck cancer	2.36e-05	0.000382	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	2.22e-05	0.00036	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—DPYD—head and neck cancer	2.07e-05	0.000335	CbGpPWpGaD
Erythromycin—ABCC1—Disease—PTGS2—head and neck cancer	2.06e-05	0.000335	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—TYMS—head and neck cancer	2e-05	0.000324	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—GSTM1—head and neck cancer	1.98e-05	0.000321	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—YAP1—head and neck cancer	1.96e-05	0.000318	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—TYMS—head and neck cancer	1.96e-05	0.000317	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—GSTM1—head and neck cancer	1.93e-05	0.000313	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—PTGS2—head and neck cancer	1.92e-05	0.000311	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—GPX1—head and neck cancer	1.89e-05	0.000307	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—CYP1A1—head and neck cancer	1.87e-05	0.000304	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—GPX1—head and neck cancer	1.85e-05	0.0003	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—CYP1A1—head and neck cancer	1.83e-05	0.000297	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—NAT2—head and neck cancer	1.82e-05	0.000295	CbGpPWpGaD
Erythromycin—ABCC1—Disease—PTEN—head and neck cancer	1.8e-05	0.000292	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—PTGS2—head and neck cancer	1.73e-05	0.00028	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—PTEN—head and neck cancer	1.67e-05	0.000272	CbGpPWpGaD
Erythromycin—ABCC1—Disease—STAT3—head and neck cancer	1.61e-05	0.000261	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—DPYD—head and neck cancer	1.6e-05	0.000259	CbGpPWpGaD
Erythromycin—ABCC1—Disease—MAPK3—head and neck cancer	1.54e-05	0.000249	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—YAP1—head and neck cancer	1.51e-05	0.000245	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—PTGS2—head and neck cancer	1.51e-05	0.000244	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—PTEN—head and neck cancer	1.51e-05	0.000244	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—TYMS—head and neck cancer	1.48e-05	0.000239	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.47e-05	0.000239	CbGpPWpGaD
Erythromycin—ABCC1—Disease—MAPK1—head and neck cancer	1.46e-05	0.000237	CbGpPWpGaD
Erythromycin—ABCC1—Disease—EGFR—head and neck cancer	1.46e-05	0.000237	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—GSTM1—head and neck cancer	1.46e-05	0.000236	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—GPX1—head and neck cancer	1.4e-05	0.000226	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—CYP1A1—head and neck cancer	1.38e-05	0.000224	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—PTEN—head and neck cancer	1.31e-05	0.000213	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.29e-05	0.000208	CbGpPWpGaD
Erythromycin—ABCC1—Disease—PIK3CA—head and neck cancer	1.27e-05	0.000206	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—PIK3CA—head and neck cancer	1.18e-05	0.000192	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—TYMS—head and neck cancer	1.18e-05	0.000191	CbGpPWpGaD
Erythromycin—ABCC1—Disease—HRAS—head and neck cancer	1.17e-05	0.00019	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—GSTM1—head and neck cancer	1.16e-05	0.000189	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—GPX1—head and neck cancer	1.11e-05	0.000181	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—PTGS2—head and neck cancer	1.11e-05	0.000181	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—CYP1A1—head and neck cancer	1.1e-05	0.000179	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—PTGS2—head and neck cancer	1.09e-05	0.000177	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—PIK3CA—head and neck cancer	1.06e-05	0.000172	CbGpPWpGaD
Erythromycin—ABCC1—Disease—AKT1—head and neck cancer	1.04e-05	0.000168	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—PTEN—head and neck cancer	9.72e-06	0.000158	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—AKT1—head and neck cancer	9.65e-06	0.000156	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—PTEN—head and neck cancer	9.5e-06	0.000154	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—PIK3CA—head and neck cancer	9.27e-06	0.00015	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—TYMS—head and neck cancer	9.09e-06	0.000147	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	9.07e-06	0.000147	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—GSTM1—head and neck cancer	8.99e-06	0.000146	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—AKT1—head and neck cancer	8.69e-06	0.000141	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—GPX1—head and neck cancer	8.6e-06	0.000139	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—CYP1A1—head and neck cancer	8.52e-06	0.000138	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—PTGS2—head and neck cancer	8.22e-06	0.000133	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—AKT1—head and neck cancer	7.58e-06	0.000123	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—PTEN—head and neck cancer	7.17e-06	0.000116	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—PIK3CA—head and neck cancer	6.86e-06	0.000111	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—PIK3CA—head and neck cancer	6.7e-06	0.000109	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—PTGS2—head and neck cancer	6.56e-06	0.000106	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—PTEN—head and neck cancer	5.72e-06	9.28e-05	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—AKT1—head and neck cancer	5.6e-06	9.08e-05	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—AKT1—head and neck cancer	5.48e-06	8.88e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—PTGS2—head and neck cancer	5.07e-06	8.21e-05	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—PIK3CA—head and neck cancer	5.06e-06	8.2e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—PTEN—head and neck cancer	4.42e-06	7.16e-05	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—AKT1—head and neck cancer	4.13e-06	6.7e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—PIK3CA—head and neck cancer	4.04e-06	6.55e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—AKT1—head and neck cancer	3.3e-06	5.35e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—PIK3CA—head and neck cancer	3.12e-06	5.05e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—AKT1—head and neck cancer	2.55e-06	4.13e-05	CbGpPWpGaD
